Modulating tumour vascular normalisation using triptolide-loaded NGR-functionalized liposomes for enhanced cancer radiotherapy

References

• Arap, W., Pasqualini, R., and Ruoslahti, E., 1998. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science, 279 (5349), 377–380.
   PubMed Web of Science ®Google Scholar
• Brown, J.M., and Wilson, W.R., 2004. Exploiting tumour hypoxia in cancer treatment. Nature reviews. Cancer, 4 (6), 437–447.
   PubMed Web of Science ®Google Scholar
• Cai, X.J., et al., 2020. Combination of metronomic administration and target delivery strategies to improve the anti-angiogenic and anti-tumor effects of triptolide. Drug delivery and translational research, 10 (1), 93–107.
   PubMed Web of Science ®Google Scholar
• Chen, J., et al., 2017. Modulation of salmonella tumor-colonization and intratumoral anti-angiogenesis by triptolide and its mechanism. Theranostics, 7 (8), 2250–2260.
   PubMed Web of Science ®Google Scholar
• Goel, S., et al., 2011. Normalization of the vasculature for treatment of cancer and other diseases. Physiological reviews, 91 (3), 1071–1121.
   PubMed Web of Science ®Google Scholar
• He, M.F., et al., 2010. Triptolide functions as a potent angiogenesis inhibitor. International journal of cancer, 126 (1), 266–278.
   PubMed Web of Science ®Google Scholar
• Jain, R., 2005. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science, 307 (5706), 58–62.
   PubMed Web of Science ®Google Scholar
• Jain, R.K., 2014. Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia. Cancer cell, 26 (5), 605–622.
   PubMed Web of Science ®Google Scholar
• Kulkarni, P., et al., 2016. Hypoxia responsive, tumor penetrating lipid nanoparticles for delivery of chemotherapeutics to pancreatic cancer cell spheroids. Bioconjugate chemistry, 27 (8), 1830–1838.
   PubMed Web of Science ®Google Scholar
• Lertkiatmongkol, P., et al., 2016. Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31). Current opinion in hematology, 23 (3), 253–259.
   PubMed Web of Science ®Google Scholar
• Li, S., Zhang, Q., and Hong, Y., 2020. Tumor vessel normalization: a window to enhancing cancer immunotherapy. Technology in cancer research & treatment, 19, 1533033820980116.
   Web of Science ®Google Scholar
• Li, X., et al., 2018. Anti-tumor effects of triptolide on angiogenesis and cell apoptosis in osteosarcoma cells by inducing autophagy via repressing Wnt/beta-catenin signaling. Biochemical and biophysical research communications, 496 (2), 443–449.
   PubMed Web of Science ®Google Scholar
• Ma, J.X., et al., 2013. Triptolide induces apoptosis and inhibits the growth and angiogenesis of human pancreatic cancer cells by downregulating COX-2 and VEGF. Oncology research, 20 (8), 359–368.
   PubMed Web of Science ®Google Scholar
• Ma, W., et al., 2014. In vivo NIRF imaging-guided delivery of a novel NGR-VEGI fusion protein for targeting tumor vasculature. Amino acids, 46 (12), 2721–2732.
   PubMed Web of Science ®Google Scholar
• Meng, L.T., et al., 2018. Tumor oxygenation and hypoxia inducible factor-1 functional inhibition via a reactive oxygen species responsive nanoplatform for enhancing radiation therapy and abscopal effects. ACS nano, 12 (8), 8308–8322.
   PubMed Web of Science ®Google Scholar
• Mukwaya, A., et al., 2019. Revascularization after angiogenesis inhibition favors new sprouting over abandoned vessel reuse. Angiogenesis, 22 (4), 553–567.
   PubMed Web of Science ®Google Scholar
• Multhoff, G., and Vaupel, P., 2020. Hypoxia compromises anti-cancer immune responses. Oxygen transport to tissue XLI, 1232, 131–143.
   Google Scholar
• Overgaard, J., 2011. Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck–a systematic review and meta-analysis. Radiotherapy and oncology, 100 (1), 22–32.
   PubMed Web of Science ®Google Scholar
• Priya, S.K., et al., 2016. Tumour angiogenesis-origin of blood vessels. International journal of cancer, 139 (4), 729–735.
   PubMed Web of Science ®Google Scholar
• Rankin, E.B., Nam, J.M., and Giaccia, A.J., 2016. Hypoxia: signaling the metastatic cascade. Trends in cancer, 2 (6), 295–304.
   PubMed Web of Science ®Google Scholar
• Schor, A., et al., 2021. Migration stimulating factor (MSF): its role in the tumour microenvironment. Tumor microenvironment: novel concepts, 1329, 351–397.
   Google Scholar
• Shen, H., et al., 2020. Hypoxia, metabolism, and the circadian clock: new links to overcome radiation resistance in high-grade gliomas. Journal of experimental & clinical cancer research, 39 (1), 129.
   PubMed Web of Science ®Google Scholar
• Srinivas, U.S., et al., 2019. ROS and the DNA damage response in cancer. Redox biology, 25, 101084.
   PubMed Web of Science ®Google Scholar
• Tirpe, A.A., et al., 2019. Hypoxia: overview on hypoxia-mediated mechanisms with a focus on the role of HIF genes. International journal of molecular sciences, 20, 6140.
   PubMed Web of Science ®Google Scholar
• Wang, X.Z., et al., 2018. Activation of natural killer T cells contributes to triptolide-induced liver injury in mice. Acta Pharmacologica Sinica, 39 (12), 1847–1854.
   PubMed Web of Science ®Google Scholar
• Winkler, F., et al., 2004. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer cell, 6 (6), 553–563.
   PubMed Web of Science ®Google Scholar
• Zhang, M.S., et al., 2015. HIF-1 alpha regulates the response of primary sarcomas to radiation therapy through a cell autonomous mechanism. Radiation research, 183 (6), 594–609.
   PubMed Web of Science ®Google Scholar
• Zheng, R.Q., et al., 2021. Targeting tumor vascularization: promising strategies for vascular normalization. Journal of cancer research and clinical oncology, 147 (9), 2489–2505.
   PubMed Web of Science ®Google Scholar